According to AstraZeneca's latest financial reports and stock price the company's current number of shares outstanding is 3,100,000,000. At the end of 2025 the company had 3,100,000,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2025 | 3.10 B | 0% |
2024 | 3.10 B | 0.06% |
2023 | 3.09 B | 0% |
2022 | 3.09 B | 0.13% |
2021 | 3.09 B | 17.91% |
2020 | 2.62 B | 0% |
2019 | 2.62 B | 3.55% |
2018 | 2.53 B | 0.08% |
2017 | 2.53 B | 0.08% |
2016 | 2.53 B | 0.08% |
2015 | 2.52 B |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
![]() Bristol-Myers Squibb BMY | 2,031,000,000 | -34.48% | ๐บ๐ธ USA |
![]() Pfizer PFE | 5,675,000,000 | 83.06% | ๐บ๐ธ USA |
![]() Merck MRK | 2,516,394,128 | -18.83% | ๐บ๐ธ USA |
![]() GlaxoSmithKline GSK | 2,038,500,000 | -34.24% | ๐ฌ๐ง UK |
![]() Sanofi SNY | 2,467,800,000 | -20.39% | ๐ซ๐ท France |
![]() Eli Lilly LLY | 897,989,151 | -71.03% | ๐บ๐ธ USA |
![]() Johnson & Johnson JNJ | 2,405,625,000 | -22.40% | ๐บ๐ธ USA |
![]() Abbott Laboratories ABT | 1,739,206,000 | -43.90% | ๐บ๐ธ USA |
![]() Biogen BIIB | 146,100,000 | -95.29% | ๐บ๐ธ USA |
![]() Novartis NVS | 1,968,000,000 | -36.52% | ๐จ๐ญ Switzerland |